Does UPADACITINIB Cause Therapeutic product effect incomplete? 803 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 803 reports of Therapeutic product effect incomplete have been filed in association with UPADACITINIB (Rinvoq). This represents 1.2% of all adverse event reports for UPADACITINIB.
803
Reports of Therapeutic product effect incomplete with UPADACITINIB
1.2%
of all UPADACITINIB reports
38
Deaths
196
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From UPADACITINIB?
Of the 803 reports, 38 (4.7%) resulted in death, 196 (24.4%) required hospitalization, and 21 (2.6%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 803 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which UPADACITINIB Alternatives Have Lower Therapeutic product effect incomplete Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL